New drug combo tested to fight Tough-to-Treat prostate cancer
NCT ID NCT04717154
Summary
This study tested whether a combination of two immunotherapy drugs could help control advanced prostate cancer that had stopped responding to standard hormone therapy. It involved 69 men whose cancer had specific genetic features that might make it more responsive to immunotherapy. Participants received the two-drug combination for four cycles, followed by a single drug for up to a year, to see if it could stop or slow the cancer's growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATIC NEOPLASMS, CASTRATION-RESISTANT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Radboudumc
Nijmegen, Gelderland, 6525GA, Netherlands
Conditions
Explore the condition pages connected to this study.